1,777
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Nanoparticle formulation increases Syzygium cumini antioxidant activity in Candida albicans-infected diabetic rats

, , , , , , , , ORCID Icon, , , ORCID Icon, & show all
Pages 1082-1088 | Received 10 Jul 2016, Accepted 13 Jan 2017, Published online: 13 Feb 2017

References

  • Ayyanar M, Subash-Babu P. 2012. Syzygium cumini (L.) Skeels: a review of its phytochemical constituents and traditional uses. Asian Pac J Trop Biomed. 2:240–246.
  • Ayyanar M, Subash-Babub P, Ignacimuthu S. 2013. Syzygium cumini (L.) Skeels., a novel therapeutic agent for diabetes: folk medicinal and pharmacological evidences. Complement Ther Med. 21:232–243.
  • Badawy EA, Rasheed WI, Elias TR, Hussein J, Harvi M, Morsy S, Mahmoud Y-L. 2015. Flaxseed oil reduces oxidative stress and enhances brain monoamines release in streptozotocin-induced diabetic rats. Hum Exp Toxicol. 34:1133–1138.
  • Bitencourt PER, Ferreira LM, Cargnelutti LO, Denardi L, Boligon A, Fleck M, Brandao R, Athayde ML, Cruz L, Zanette RA, et al. 2016. A new biodegradable polymeric nanoparticle formulation containing Syzygium cumini: phytochemical profile, antioxidant and antifungal activity and in vivo toxicity. Ind Crop Prod. 83:400–407.
  • Bitencourt PE, Bona KS, Cargnelutti LO, Bonfanti G, Pigatto A, Boligon A, Athayde ML, Pierezan F, Zanette RA, Moretto MB. 2015. Syzygium cumini seed extract ameliorates adenosine deaminase activity and biochemical parameters but does not alter insulin sensitivity and pancreas architecture in a short-term model of diabetes. J Complement Integr Med. 12:187–193.
  • Boligon AA, Brum TF, Frolhich JK, Froeder ALF, Athayde ML. 2012. HPLC/DAD profile and determination of total phenolics, flavonoids, tannins and alkaloids contents of Scutia buxifolia Reissek stem bark. Res J Phytochem. 6:84–91.
  • Bonifácio BV, Silva PBD, Ramos MADS, Negri KMS, Bauab TM, Chorilli M. 2014. Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine 9:1–15.
  • Buchta V, Matula V, Kestřánek J, Vejsová M, Křivčíková L, Špaček J. 2013. Je diabetes mellitus rizikový faktor kvasinkového poševního zánětu? [Is diabetes mellitus a risk factor in genital yeast infections?]. Česká Gynekol. 78:537–544.
  • Buege JA, Aust SD. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302–310.
  • Conte R, Luca I, Luise A, Petillo O, Calarco A, Peluso G. 2016. New therapeutic potentials of nanosized phytomedicine. J Nanosci Nanotechnol. 16:8176–8187.
  • Enjalbert B, MacCallum M, Odds FC, Brown AJP. 2007. Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infect Immun. 75:2143–2151.
  • Feng Y, Sun C, Yuan Y, Zhu Y, Wan J, Firempong CK, Omari-Siaw E, Xu Y, Pu Z, Yu J, et al. 2016. Enhanced oral bioavailability and in vivo antioxidant activity of chlorogenic acid via liposomal formulation. Int J Pharm. 30:342–349.
  • Ferriz JM, Vinová J. 2010. Prodrug design of phenolic drugs. Curr Pharm Des. 16:4491–4499.
  • Fisher MA, Lee PG, Tarry WF. 1989. Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats. Antimicrob Agents Chemother. 33:1042–1045.
  • Horak E, Hopfer SM, Sunderman FW. Jr, 1981. Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity. Clin Chem. 27:1180–1185.
  • Hu H, Nie L, Feng S, Suo J. 2013. Preparation, characterization and in vitro release study of gallic acid loaded silica nanoparticles for controlled release. Pharmazie. 68:401–405.
  • International Diabetes Federation (IDF). 2015. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation.
  • Kade IJ, Ogunbolude Y, Kamdem JP, Rocha JBT. 2014. Influence of gallic acid on oxidative stress-linked streptozotocin-induced pancreatic dysfunction in diabetic rats. J Basic Clin Physiol Pharmacol. 25:35–45.
  • Kaloriti D, Jacobsen M, Yin Z, Patterson M, Tillmann A, Smith DA, Cook E, You T, Grimm MJ, Bohovych I, et al. 2014. Mechanisms underlying the exquisite sensitivity of Candida albicans to combinatorial cationic and oxidative stress that enhances the potent fungicidal activity of phagocytes. MBio. 5:e01334–e01314.
  • Komala MG, Gross S, Mudaliar H, Huang C, Pegg K, Mather A, Shen S, Pollock CA, Panchapakesan U. 2014. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice. PLoS One. 9:e108994.
  • Koroglu P, Senturk GE, Yucel D, Ozakpinar OB, Uras F, Arbak S. 2015. The effect of exogenous oxytocin on streptozotocin (STZ)-induced diabetic adult rat testes. Peptides. 63:47–54.
  • Krisman CR. 1962. A method for the colorimetric estimation of glycogen with iodine. Anal Biochem. 4:17–23.
  • Lee SH, Nam BY, Kang EW, Han SH, Li JJ, Kim DH, Kim SH, Kwak SJ, Park JT, Chang TI, et al. 2010. Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy. Nephrol Dial Transplant. 25:2134–2141.
  • Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, et al. 2007. Urinary N-acetyl-beta-(d)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 18:904–912.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
  • Meng S, Cao J, Feng Q, Peng J, Hu Y. 2013. Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid Based Complement Alternat Med. 2013:801457.
  • Miramón P, Dunker C, Windecker H, Bohovych IM, Brown AJP, Kurzai O, Hube B. 2012. Cellular responses of Candida albicans to phagocytosis and the extracellular activities of neutrophils are critical to counteract carbohydrate starvation, oxidative and nitrosative stress. Plos One. 7:e52850.
  • Mora-Huertas CE, Fessi H, Elaissari A. 2010. Polymer-based nanocapsules for drug delivery. Int J Pharm. 385:113–142.
  • Moresco RN, Sangoi MB, De Carvalho JA, Tatsch E, Bochi GV. 2013. Diabetic nephropathy: traditional to proteomic markers. Clin Chim Acta. 421:17–30.
  • Munro CA, Winter K, Buchan A, Henry K, Becker JM, Brown AJ, Bulawa CE, Gow NA. 2001. Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity. Mol Microbiol. 39:1414–1426.
  • Nallamuthu I, Devi A, Khanum F. 2015. Chlorogenic acid loaded chitosan nanoparticles with sustained release property, retained antioxidant activity and enhanced bioavailability. Asian J Pharm Sci. 10:203–211.
  • Niimi K, Niimi M, Shepherd MG, Cannon RD. 1997. Regulation of N-acetylglucosaminidase production in Candida albicans. Arch Microbiol. 168:464–472.
  • Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358.
  • Prince PSM, Menon VP, Pari L. 1998. Hypoglycaemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J Ethnopharmacol. 61:1–7.
  • Quintanar-Guerrero D, Alléman E, Doelker E, Fessi H. 1998. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharm Res. 15:1056–1062.
  • Rasoanaivo P, Wright CW, Willcox ML, Gilbert B. 2011. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malar J. 10(Suppl 1):S4.
  • Rezaei-kelishadi M, Nuri M, Erfani Z, Palizban A, Parandin R. 2014. Control, management and treatment of diabetes using modern drug delivery systems and special properties of nanoparticles. J Biol Today's World. 3:206–211.
  • Saklani R, Gupta SK, Mohanty IR, Kumar B, Srivastava S, Mathur R. 2016. Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats. Mol Cell Biochem. 420:65–72.
  • Sharma S, Sahni JK, Ali J, Baboota S. 2015. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies. Drug Deliv. 22:541–551.
  • Selmeci L. 2011. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? Free Radic Res. 45:1115–1123.
  • Srivastava S, Chandra D. 2013. Pharmacological potentials of Syzygium cumini: a review. J Sci Food Agric. 93:2084–2093.
  • Tian H, Tang Z, Zhuang X, Chen X, Jing X. 2012. Biodegradable synthetic polymers: Preparation, functionalization and biomedical application. Prog Polym Sci. 37:237–280.
  • Tiwari BK, Kumar D, Abidi AB, Rizvi SI. 2014. Efficacy of composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats. ISRN Pharmacol. 2014:608590.
  • Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, et al. 2008. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 1:200–208.
  • Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B. 1998. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 161:2524–2532.